The purpose of the present study was to assess the effects of low-dose ketamine on spontaneous brain electrical activity (EEG) 
Le but de cette ~tude gtait d' ~valuer les effets de petites doses de k~tamine sur l'activit~ electrique spontange du cerveau (EEG) en corrdlation avec le changement de la v~locit~ du d~bit sanguin c&gbral. Vingt volontaires sains ~taient divis~s en deux groupes d'une faqon randomis~e. Le groupe I (n = 10) a recu une dose de 0,25 rag" kg -1 de ketamine ; le groupe H (n = 10) a re~u 0,5 mg. kg -1 de ketamine par voie intraveineuse. Les paramdtres suivants ~taient m~sur~s : la pression arterielle moyenne (MAP), la fr~quence cardiaque (HR), la PC02 en fin d'expiration (PETC02) et la saturation art~rielle en oxyg~ne (Sa02). L'EEG dtait enregistrg ~ l'aide d'~lectrodes adhgsives placdes sur la rdgion temporo-occipitale des deux h~misph~res. La v~locitd du d~bit sanguin dans l'artOre c&~brale moyenne (MCA) ~tait mesur~e par un doppler trans-crdnien (TCD)
There is some controversy about the effects of ketamine on brain electrical activity (EEG) and intracranial haemodynamic variables. Ketamine has been reported to depress the thalamic-median nucleus selectively. 1,2 In contrast, Kayama and Iwama 3 found that the administration of ketamine resulted in functional stimulation of both neo-cortical and hippocampal areas. The effects of ketamine on cerebral blood flow (CBF) and cerebral oxygen consumption (CMRO2) are also controversial. 4-s Noninvasive transcranial Doppler sonography (TCD) measures blood flow velocity in human basal cerebral arteries continuously. 9"~~ Since TCD does not interfere with neurophysiological recordings it may be used to correlate changes in cerebral blood flow velocity with changes in brain electrical activity. The purpose of this study was to evaluate simultaneously the effects of ketamine on EEG and intracranial blood flow velocity.
Methods
Twenty healthy volunteers (ASA physical status I; age: 27 -5 yr; female: 12; male: 8) were included in the study. This study was approved by the Institutional Ethics Committee and written informed consent was obtained. The unpremedicated subjects were randomly assigned to one of two groups. Subjects of Group I (n = 10) received 0.25 mg" kg -1 ketamine iv and subjects of Group II(n = 10) 0.5 mg. kg -I ketamine iv. The following variables were recorded at baseline and for 60 min following ketamine administration: EEG, TCD, heart rate (HR, beats/min, RM300 ~ Honeywell), mean arterial blood, pressure (MAP, mmHg; Dinamap ~, Critikon), end-tidal PCO2 (PETCO2, mmHg; Datex ~ Hoyer) and arterial oxygen saturation (SaO2, %; Nellcor ~ Draeger).
emitting frequency (pulse repetition: 5-10 Hz, burst width: 13 p.sec). The MCA was identified by a transtemporal approach using flow direction discrimination (flow towards the probe), depth control and audio analysis. Following FFT of the Doppler frequency shift, systolic and mean flow velocity (Vsyst, Vmean; cm-sec -1) were recorded.
Statistical analysis
All results are expressed as mean • SEM. Comparisons were made by analysis of variance (ANOVA) for repeated measurements, followed by t tests with Bonferroni corrections. Pearsons's correlation coefficients were calculated between EEG power spectra and TCD data. Statistical significance was assumed at a P --< 0.05.
Results
All subjects became unconscious within 73 ---15 sec after ketamine administration. Onset of unconsciousness was not different between groups. Data for HR, MAP, SaO2 and PETCO2 are shown in the Table. In both groups HR and MAP increased within two minutes following ketamine without intergroup differences. Haemodynamic baseline values were regained after 7 --+ 1 min (Group I) and 13 • 3 min (Group II), respectively. The SaO2 did not change over time and PETCO2 remained constant within each group.
EEG
Platinum needle electrodes (13L70, Dantec, Denmark) for EEG recordings were placed in the scalp at C3P3 and C4P4 according to the International 10-20 system. For artifact control, the electro-oculogram (EOG) was recorded from supra-vs infraorbital leads with the bandpass for all recordings set at 0.5-45 Hz. The inter-electrode impedances were kept below 5 kOhm (at 12 Hz). After amplification (BIO-V6 ~, nbn-electronics, Germany) the EEG and EOG signals were stored on magnetic tape (Store 7-DS ~, Racal, Great Britain). Following A/D conversion (ced 1401 ~ Cambridge Electronics, Great Britain) and digitization (200 Hz sampling rate) EEG segments of 5.2 sec duration were processed by Fast Fourier Transformation (FFT, Kaiser window, -40 dB sidelobe suppression). Spectral power densities for selected frequency bands (delta: 0.5-3.9 Hz, theta: 4.0-7.9 Hz, alpha: 8.0-12.9 Hz, beta: 13.0-45.0 Hz) were calculated from the amplitude spectra.
TCD
Blood flow velocity in the middle cerebral artery (MCA) was measured as reported previously 9'~~ using a pulsed transcranial Doppler ultrasound system (TC2-64B | EME, Germany). The TCD device operates at 2 MHz EEG In seven subjects of Group I and eight of Group II dominant alpha-activity was present during baseline recordings. In all other subjects dominant frequency extended from fast theta to alpha frequency (6-12 Hz). Following ketamine administration, alpha-activity was decreased by 79 ---8% in both groups. At the same time synchronous high-voltage theta-activity was recorded in both groups. Theta power increased by 89 ---11% in Group I and by 229 ---29% in Group II. This was associated with dose-dependent increases in delta-(Group I: 34 • 6%; Group II: 154 • 13%) and beta-activity (Group I: 25 ---4%; Group II: 54 • 6%). As a result, total EEG-power was increased in both groups (Figure 1) . In Group I this increase in total power faded within 6 ---2 min and in Group II within 14 • 4 min.
Following ketamine administration Vmean increased by 35 -7% in Group I and by 68 ---10% in Group II (P < 0.05) (Figure 2) . The Vmean was different between the groups at 2 to 12 min following ketamine administration (P < 0.05). In Group I Vsyst did not change over time. In Group II Vsyst increased by 45 • 9% within two to five min following ketamine (P < 0.05). In group I baseline Heart rate (HR), mean arterial blood pressure (MAP), arterial oxygeu saturation (SaO2) and end-tidal PCO2 (PETCO2) following low-dose ketamine (mean ---SD). Group I (n = 10): ketamine 0.25 rag' kg-t; Group II (n = 10): 0.50 mg. kg-~ ketamine; significance: * vs baseline within group; i vs Group I at each respective time level; P < 0.05).
data were reestablished within 9 ---3 min. Vsyst and Vmean were increased over a period of 15 ---4 min following ketamine in Group II.
Correlation between EEG and TCD
The correlation of increases in theta-activity and Vmean was r = 0.79 (P < 0.01) in Group I and r = 0.86 (P < 0.01) in Group II. Correlations between MAP and Vmean were r = 0.41 (P > 0.05) in Group I and r = 0.49 (P > 0.05) in Group II.
Discussion
In the present study, ketamine produced dose-dependent increases in delta-, theta-, and beta-activity. This was paralleled by dose-dependent increases in MCA blood flow velocity. These changes were not correlated with systemic haemodynamic changes or variations in PETCO 2. Our results suggest that ketamine-induced increases in Vmean are produced by neuronal activation. In contrast to most other anaesthetics, the anaesthetic effects of ketamine are associated with activation of cerebral function resulting in synchronized theta-and desynchronized beta-activity. Kayama and Iwama reported the appearance of synchronous high-voltage slow wave activity following ketamine (2 to 5 mg'kg -1) in unrestrained cats. 3 In agreement with previous studies, 11 ketamine decreased alpha-activity and increased thetaactivity with smaller increases in delta-and beta-activity. The EEG slow waves following short-lasting desynchronization has been interpreted as a correlate of ketamineinduced seizure activity in subcortical and neocortical areas. 3'12 Even though no spike-and-wave complexes as an indicator for the occurrence of seizure activity or electrical correlates of myocloni were observed, the twitching of face or limb muscles seen in some volunteers may be related to these electrical phenomena.
The effect of ketamine on cerebral metabolism is controversial. 4-8 It has been shown that increases in EEG activity are associated with increases in neuronal metabolism. 13,14 Since cerebral metabolism was not measured in the present study it remains speculative if the appearance of high-voltage hypersynchronuous slow-wave activity are related to ketamine-induced cerebral metabolic stimulation. 4, 7 Ketamine has been found to cause variable CBF changes, from an 80% increase 4 to a 50% decrease, s'6 Discontinuous CBF measurements may result in decreased sensitivity to transient changes in cerebral haemodynamics. Here, we continuously recorded intracranial blood flow velocity using noninvasive TCD-monitoring. 9,1~ The dose-dependent increases in MCA blood flow velocity cannot be explained by changes in HR, MAP. Even though PETCO2 was different between groups it did not change over time in either group. In humans the cerebral vascular response to COE is not altered by ketamine. 15 Our results are thus consistent with the view that ketamine alters cerebral haemodynamics due to its cerebral rather than to its peripheral vascular effects, to Even though this response is not strictly linear the present study demonstrates that increases in blood flow velocity are correlated with increases in thetaactivity and EEG total power. Together, our data indicate concurrent stimulation of both neuronal activity and cerebrovascular haemodynamics.
The CBF cannot be measured directly using TCD because the diameter of the insonated vessel segment (MCA) is unknown. However, experimental studies using anaesthetics and narcotics have shown that changes in CBF are correlated to changes in Vmean. 16A7 The present experiments indicate only minor changes in the diameter of the proximal MCA under these conditions. Our data suggest that dose-dependent changes in Vmean following ketamine reflect relative CBF changes since the insonation angle and depth of insonantion were maintained constant over time and systemic hemodynamics were not different between groups. It is possible that MCA blood flow velocity changes following ketamine are not related to hemodynamic effects of the drug but to changes in neuronal activity. Our study demonstrates that 0.25 mg-kg -1 and 0.50 mg. kg-x ketamine produces stimulation of brain electrical activity in parallel to dose-dependent increases in intracranial blood flow velocity. The authors conclude that simultaneous recordings of brain electrical activity and cerebral blood flow velocity may be a valuable tool for continuous monitoring of anaesthetic-induced changes of both functional and cerebral haemodynamic variables.
